Tadalafil oral soluble film and preparation method thereof

The invention provides a tadalafil oral soluble film and a preparation method thereof. The tadalafil oral soluble film comprises the following components in percentage by weight: 5-20% of tadalafil, 10-80% of a film forming material, 0.1-20% of a plasticizer, 0.5-10% of an acid stabilizer, 0.1-10% of a surfactant, 0.1-10% of a sweetening agent and 0.1-5% of a flavoring agent. According to the tadalafil oral soluble film disclosed by the invention, the tadalafil oral soluble film can be prepared by smoothly utilizing a hot-melt extrusion film drawing process, the impurity content in the preparation process can be effectively controlled, and the prepared tadalafil oral soluble film has good storage stability..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 05. Jan. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

LU WEI [VerfasserIn]
WANG ZHONGNENG [VerfasserIn]
ZHAO JIAN [VerfasserIn]
ZHAO YINGCHAO [VerfasserIn]
HU WEIZHI [VerfasserIn]
GUO CAIHONG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61J: Containers specially adapted for medical or pharmac (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che
med

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22

Patentnummer:

CN117338753

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000880833